Dutchland, Denver, PA), penicillin (100 U/ml), streptomycin (100 ug/ml), gentamycin (10 kg/ml), L-glutamine (2 mM), 2-ME (5 X 10-5 M), and a-methyl mannoside (60 mM) . Another IL-2-dependent T cell line, CTLL-2 (13), was obtained from the American Type Culture Collection (Rockville, MD) and was maintained in a 1 :1 mixture of murine spleen cell Con A SN and RPMI 1640 containing 25 mM HEPES and 5% heat-inactivated FCS, penicillin (100 U/ml), streptomycin (100,ug/ml), gentamycin (10 Fcg/ml), L-glutamine (2 mM), sodium pyruvate (2 mM) and a-methyl-mannoside (60 mM). Six other T cell lines were maintained as described and included the alloreactive T cell line, PK 7.1-E10 (11); two long-term murine T cell clones of common origin, clone 96 and clone 29 (14) , which are used as indicator cells in an IL-2 assay and one of which (clone 96) has been shown to possess cytotoxic activity against P815 mastocytoma cells (15) , and the CBA anti-A.AL cytotoxic T cell lines L. 13 .D.4A, L.13 .D.8, and L.13.D.17 (16) . Th lines specific for KLH, BK-2, 8-5 (17) , and A-12 were maintained by a modification ofthe method described by Kimoto and Fathman (18) , by 7-d antigenic stimulation and rest cycles in cultures containing irradiated syngeneic spleen cells and murine Con A SN.
Reagents and mAbs. Affinity-purified anti-BSF-I mAb 11B11 (19) and its isotypematched control, 50C1 (anti-DNP), were kindly provided by Drs . Ohara and Paul (National Institutes of Health, Bethesda, MD) . The anti-IL-2 mAb, DMS-1, which reacts with human and murine IL-2, was purchased from Genzyme (Boston, MA). Ascites fluid containing the anti-murine IL-2-R mAb, AMT-13, and its isotype-matched control, 23/7, were prepared as described previously (20) . The AMT-13 ascites contained 0.5 mg/ml of antibody . rIL-2 was obtained from AmGen Biologicals (Thousand Oaks, CA) .
Preparation of IL-2 and BSF-1-containing SN. SN from PMA-stimulated EL-4 thymoma cells was prepared as described previously (21) . Such SN contained high levels of IL-2 activity and negligible levels of BSF-1 activity.
SN from Con A-pulsed PK 7.1 cells were prepared as described previously (11) . Such SNs contained greater than 103 U/ml of BSF-1 activity and were devoid of IL-2 activity .
BSF-1 Assay. BSF-I activity was measured by a modification (22, 23) of the previously described anti-IgM costimulation assay (1) . 5 X 10' small (1 .083-1 .222 g/ml), Percollfractionated B cells (23) were cultured for 3 d in a volume of 200 Al containing 10 U1 of a 10% suspension of goat anti-mouse Ig coupled to Sepharose (S-GAMIg) (22, 24) and SN or purified lymphokines (20 ul) . The cells were then pulsed with 1 UCi/well of ['H]thymidine and harvested 16 h later. 1 U of BSF-I was designated as the reciprocal of the dilution containing 50% of the maximal activity of a standard BSF-1-containing PK 7.1 SN .
IL-2 Assay. IL-2 activity was assayed by measuring the [3H]thymidine uptake of IL-2-dependent HT-2 (12) or CTLL-2 (13) cell lines in response to IL-2-or to BSF-1-containing SN . One HT-2 line has been maintained in our laboratory for 3 yr and the other was recently obtained from Dr. Robert Coffman (DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA) . For the assay, 20-ul aliquots/well of a 2 .5 X 105 cells/ml suspension were added to 70 j1/well of different dilutions of the BSF-1 or IL-2-containing SN. Cells were pulsed with 1 ACi/well of [3H]thymidine after 48 h of incubation at 37°C/5% COz in air, and 16 h later the cells were harvested.
IL-2 Assay on T Cell Blasts. Murine Con A T cell blasts were prepared as described by Malek et al . (25) . For the assay, the cells were cultured at a density of 2 .5 X 10 5 cells/ml in 200 Al/well of assay medium containing various dilutions of the IL-2-or BSF-1-containing SN or the purified lymphokines . After 48 h the cells were pulsed with 1 ,uCi/well of [3H]thymidine, and 16 h later the cells were harvested .
B Cell Growth Factor (BCGF) II Assay. BCGF-II activity was assayed by measuring the ability of the SN or purified lymphokines to synergize with dextran sulfate (DxS) in a B cell proliferation assay (26) . B cells were not subjected to a Percoll density gradient fractionation before culture, since BCGF-II acts on low density B cells (23) . Test SN were added on day 0, on day 3 cells were pulsed with [3H]thymidine, and were harvested 16 h later .
BCDF for IgGI (BCDF -'Y) Assay. BCDF-,y activity was measured as described previously (6, 27) , using B cells prepared as described for the BCGF-II assay. 20 ug/ml LPS was [sH]thymidine incorporation of HT-2 cells cultured in the presence of serial twofold dilutions of IL-2-containing EL-4 SN (0) and the BSF-1-containing PK 7 .1 SN (O) . SNs were prepared, and [sH]thymidine incorporation assays were performed as described in Materials and Methods .
added at the initiation of culture and BSF-1 was added a day later. On day 6, the culture SN were assayed for IgGI by a RIA .
BCDF for IgM (BCDF-,u) Assay . SN or purified lymphokines were tested for BCDF-A activity by their ability to stimulate the secretion of IgM from the in vitro-adapted BCL, cell line, 3113 (28) . T cell SN were added on day 0, and on day 6 the culture SNs were assayed for IgM by a /A-specific RIA .
Gel Filtration . Gel filtration of the different SN was carried out at 4°C using a 2 .5 X 50 cm Sephacryl S-200 column (Pharmacia Fine Chemicals, Uppsala, Sweden) equilibrated with Tris-buffered saline (50 mM, pH 7 .4) containing 0 .1 % sodium azide . After chromatography, BSA was added to the different fractions at a final concentration of 1 mg/ml, and the fractions were dialyzed against 3 changes of PBS (3 X 1 liter) and once against RPMI-1640 (1 X 1 liter) .
Purification of IL-2 and BSF-1 . The initial step in the partial purification of IL-2 or BSF-1 was carried out as described (10, 29) by adsorption to trimethylsilyl-coated TMSCpG and subsequent elution by a 50% acetonitrile/0 .2 M NaCl/0 .1 % TFA solution . This procedure resulted in the adsorption of >95% of the BSF-1 or IL-2 activities from the SN with minimal contamination by BCGF-I1 and BCDF-ft activities . Reverse-phase HPLC was carried out as described previously (10) , in a model 332 gradient liquid chromatograph (Beckman Instruments, Inc ., Fullerton, CA) and an Altex Ultrasphere ODS (250 X 4 .6 mm, 5 pm) reverse-phase column (Altex Scientific, Berkeley, CA) .
Results
HT-2 Growth-promoting Activity of PK 7 .1 SN. The HT-2 cell line was derived from T cells that provide IA d-restricted help to B cells for an anti-SRBC response . The requirement of HT-2 cells for the growth-promoting activity of IL-2 is the basis for the 1L-2 assay used by many laboratories (12) . However, when HT-2 cells were cultured with T cell SN lacking IL-2, namely, PK 7.1 (11), the HT-2 cells proliferated, as judged by both [sH]thymidine incorporation and by an increase in cell number . As shown in Fig . 1 , the stimulation indexes obtained at maximal stimulatory concentrations of BSF-1-containing PK 7 .1 SN were about 50% as high as those obtained with maximal stimulatory concentrations of the IL-2-containing EL-4 SN . Proliferation was observed at 24, 48, and 72 h using the ['H]thymidine incorporation assay, and was not affected by the inclusion of a-methyl-mannoside (20 mg/ml) in the medium (data not shown), suggesting that the proliferative activity of SN from Con A-pulsed PK 7 .1 cells is not due to contaminating Con A.
Purification of IL-2 and BSF-1 . When subjected to gel filtration on Sephacryl S-200 columns, the HT-2 growth-promoting activity of EL-4 cell SNs eluted with FIGURE 2 . HPLC elution profiles of the HT-2 growth-promoting (*) and BSF-1 (0) activities from EL-4 (A) and PK 7.1 (B) cell SNs. SNs were adsorbed with TMS-CpG (Sepralyte, 40 /.Lm) and the IL-2 or BSF-1 activities eluted from the beads with 50% acetonitrile in 0.2 M NaCl/0 .1 % TFA. The eluates were lyophilized, reconstituted with distilled water and applied to a reverse-phase Altex Ultrasphere ODS column .
an apparent M, of 30,000, in concordance with a previous report (30) . The HT-2 growth-promoting activity of PK 7 .1 SN, however, coeluted with BSF-1 and had an apparent Mr of 18,000 . No IL-2 activity was detected in the PK 7 .1 SN and no BSF-1 activity was detected in the EL-4 SN .z
To characterize further the HT-2 growth-promoting activity present in PK 7.1 SN, both HT-2 growth-promoting activity and BSF-1 activity were purified from PK 7 .1 SN by TMS-CpG adsorption and reverse-phase HPLC, as described (10) . IL-2 was purified from EL-4 SN by the same procedure. The beads absorbed the HT-2 growth-promoting activities from both SN and the anti-Ig-mediated costimulator and BCDF-y activities from the PK 7 .1 SN . The 50% acetonitrile eluates that contained all three activities were then subjected to reverse-phase HPLC, as described in Materials and Methods. As shown in Fig. 2A , the IL-2 activity from the EL-4 SN eluted at 60-80% acetonitrile . No BSF-1 activity was detected in the original EL-4 SNs, nor in any of the HPLC fractions. Using a system similar to the one described here, the BSF-1 activity has been reported to elute at acetonitrile concentrations of 47-49% (10, 31). As shown in Fig. 2B , both the BSF-1 and the HT-2 growth-promoting activities present in the PK 7.1 SN coeluted at 47-50% acetonitrile . No HT-2 growth-promoting activity was detected in those fractions in which IL-2 should have eluted (60-80% acetonitrile) . The fractions containing the BSF-1 activity were, as expected, also positive for BCDF-y activity, according to previous reports by our group (6) and other (32, 33) that BSF-1 and BCDF-y are identical. No BCGF-11 or BCDF-,u activities were detected in these fractions.
Fffect ofAnti-BSF-1 mAb, 11B11. The above results indicated that the material containing the HT-2 growth-promoting activity and isolated from the PK 7.1 SN was different in size and polarity from the material containing the IL-2 z Several sublines of EL-4 cells have been generated in our laboratory . After stimulation with PMA, some lines secrete only IL.-2 and others secrete both IL-2 and BSF-1 . Inhibition of HT-2 growth-promoting activity of purified BSF-1 but not purified IL-2 by mAb to BSF-1 . Constant amounts of BSF-I or IL-2 were preincubated for 30 min at room temperature with the indicated dilutions of a 1 mg/ml stock of monoclonal anti-BSF-1, 1 1 B 11 (") or isotype-matched control antibodies, 50C 1 (Q) . HT-2 cells were then added and proliferation was measured . Results represent the mean of triplicate experiments ± SEM .
[s H]Thymidine incorporation of cells cultured in the absence of added lymphokines was 2,765 ± 254 cpm.
-LOG,, ANTIBODY DILUTION FIGURE 4 . Inhibition of anti-Ig costimulator activity of BSF-1 by mAb to BSF-1 . The indicated dilution of a 1 mg/ml stock of mAbs 111311 (0) or 50C1 control (O) were preincubated at room temperature for 60 min with constant amounts of BSF-1 . GAMIg-S and aliquots from a small B cell suspension were added, and BSF-1 activity was assayed as described in Materials and Methods . Results represent the mean of triplicate experiments ± SEM .
[s H]Thymidine incorporation of cells cultured in the absence of added lymphokines was 737 ± 298 cpm. activity isolated from the EL-4 SN . The former was similar to BSF-1 based on its physicochemical properties . We, therefore, postulated that BSF-1 had IL-2-like growth-promoting activity on HT-2 cells . To test this hypothesis and to disprove the possibility of contamination of BSF-1 by an IL-2 species with physicochemical properties similar to those of BSF-1, we tested the effects of soluble anti-BSF-1 mAbs (I IB11), previously reported to inhibit BSF-1 activity (19), on both the BSF-1 and HT-2 growth-promoting activities of the purified BSF-1 and IL-2 preparations from PK 7.1 and EL-4 SN, respectively . As shown in Fig . 3A , the HT-2 growth-promoting activity purified from PK 7.1 SN was readily inhibitable by I IBI 1 antibody, but not by an isotype-matched anti-DNP antibody (50C1). In contrast, the HT-2 growth-promoting activity of the EL-4-derived IL-2 was not affected by I IB11 (or the control antibody) at any of the antibody concentrations tested (Fig . 3B) .
The mAb 1 1 B 1 1 completely blocked the anti-Ig-mediated costimulator activity of the PK 7 .1-derived BSF-1 at the same concentrations that inhibited the BSF-1-mediated proliferation of HT-2 cells (Fig . 4) . Anti-IL-2 mAb Does Not Block the HT-2 Growth-promoting Activity of BSF-1. To obtain additional evidence that the HT-2 growth-promoting activity of purified BSF-1 was not due to contaminating IL-2, and to investigate whether the BSF-1-mediated proliferation of HT-2 cells was due to autocrine production and utilization of IL-2 in response to BSF-1, soluble anti-IL-2 mAb (DMS-1) was added to cultures of HT-2 cells containing purified BSF-1 or rIL-2 . The anti-IL-2 mAb failed to inhibit the proliferation caused by BSF-1, whereas the same concentrations of antibody inhibited the rIL-2-mediated proliferation of HT-2 cells by 50-60% (Fig . 5) . These results suggest that BSF-1 purified from PK 7 .1 SN has both growth-promoting activity on HT-2 cells and anti-Ig-mediated costimulatory activity on resting B cells, and that neither activity can be accounted for by contaminating or autocrine IL-2 .
Anti-IL-2-R mAb Blocks the Growth-promoting Activity of IL-2 but not BSF-1 on HT-2 Cells . Although the above results indicate that the HT-2 growth-promoting activity of BSF-1 was not due to IL-2 contamination or mediated by autocrine IL-2 production, the proliferative signal given by BSF-1 might have resulted from interaction with IL-2-R . To test this possibility, the anti-IL-2-R antibody, AMT-13, previously shown to inhibit IL-2 binding and IL-2-mediated proliferation in activated murine T cells (20) , was added to cultures of HT-2 cells stimulated with rIL-2 or BSF-1 . AMT-13 antibodies blocked (by^-70%) the proliferation caused by HL-2 but did not affect the proliferation mediated by BSF-1 (Fig . 6 ) . These result suggest that BSF-1 and IL-2 do not bind to the same receptor, or at least the same epitope on the IL-2-R on HT-2 cells, even though both induce their growth . The nature of the BSF-1 receptor on HT-2 cells is not known .
Morphology ofHT-2 Cells Cultured with BSF-1 or rIL-2 . When HT-2 cells were cultured with purified BSF-1, they showed striking changes in morphology (Fig .  7A ) when compared with HT-2 cells cultured with IL-2 (Fig . 7B) . While the cells cultured with IL-2 usually maintained a rounded shape, grew in suspension, and formed small clusters, the cells cultured in BSF-1 acquired a flattened appearance, produced numerous dendritic-like cytoplasmic projections, and attached to the surface of the culture flask . The percentage of cells undergoing (Fig . 8) . As shown in Fig. 8 , the IL-2 preparation supported the growth of all the T cell lines tested . In contrast, the BSF-1 preparation supported the growth of the Th populations (C-E) and both HT-2 cell lines (A-B), but induced only a modest proliferation of Con A T cell blasts (M), and no significant proliferation of the other T cell lines, including cytotoxic, alloreactive, and long-term T cell lines (Fig . 8 F-L) . These results suggest that BS F-1 may act as a growth factor for only some T cell subsets. Based on the T cells tested to date, it appears that BSF-1 acts primarily on T cells that provide help to B cells . It will be necessary to test the effect of BSF-1 on additional T cell lines and clones to determine if additional subsets of cells are responsive . Microphotographs were taken after 48 h of culture using an inverted phase contrast microscope .
Discussion
The major finding to emerge from these studies is that BSF-I, in addition to its known effects on B cells, also induces the proliferation of some subsets of T cells such as HT-2 cells and antigen-specific Th (that provide help to B cells) . references 34 and 35) , it was essential to show that the growth-promoting activity of BSF-I was not due to the presence of contaminating IL-2 . To this end, it was shown that (a) PK 7 .1 SNs, which lack IL-2 activity, support the proliferation of HT-2 cells^-50% as well as IL-2-containing EL-4 SNs; (b) The HT-2 growthpromoting activity present in PK 7 .1 SNs copurifies with BSF-1 by both gel filtration and reverse-phase HPLC ; (c) The proliferation of HT-2 cells in response to purified BSF-1, but not to IL-2, is inhibited by anti-BSF-1 mAbs . The same antibodies block the anti-Ig-mediated costimulatory activity of BSF-1 ; (d) anti-IL-2 mAbs block the HT-2 growth-promoting activity of IL-2 but not BSF-1 ; (e) anti-IL-2R mAbs block the HT-2 growth-promoting activity of IL-2 but not BSF-1 ; and (f) BSF-1 preparations that support the growth of HT-2 cells do not induce significant proliferation of other IL-2-dependent T cell lines, with the exception of antigen-specific Th lines. In contrast, IL-2 supports the growth of all the T cell lines and normal T cell blasts tested .
We have chosen the PK 7.1 SN as a source of BSF-1 because of its paucity of IL-2 activity and its high levels of BSF-1 activity (11) . Other T cell lines or clones that fail to secrete IL-2 but secrete BSF-1 and/or other lymphokines that act on B cells have been described (36) (37) (38) (39) . In the last year, there have been several reports describing the partial purification of BSF-1 (10, 31, 32) , and the cloning and expression of the BSF-I cDNA (33) . In these reports, no T cell growthpromoting activity associated with BSF-1 was described. One possible explanation is that two groups (31, 32) used cytotoxic, IL-2-dependent T cell lines (CSP 2.1 and CTLL-2, respectively) as indicator cells in their IL-2 assays . All cytotoxic or alloreactive T cell lines tested to date in our system have also failed to proliferate significantly in response to BSF-1 . Paradoxically, however, Ohara et al . (10) used HT-2 cells in their IL-2 assay and could not detect any HT-2 growth-promoting activity associated with their purified BSF-1 . This observation could be explained by the fact that they used cloned IL-2-dependent T cells from the HT-2 line . During the cloning process, the cells might have lost responsiveness to BSF-1, while retaining responsiveness to IL-2 . Another possible explanation is that the HT-2 growth-promoting activity associated with PK 7.1-derived BSF-1 is related to its cell source . However, this possibility appears unlikely since we have recently purified BSF-I from BSF-I-containing SN of EL-4 cells, and found that it behaves identically to that isolated from PK 7.1 SNs (unpublished observations). If BSF-I acts primarily on Th (L3T4+, Lyt-2-), then the observation that BSF-1 induced only modest proliferation of Con A-activated T cells could be explained by the fact that Con A induces the preferential proliferation of Lyt-2+ cells (40) . In support of this possibility is the finding that immunofluorescence staining of Con A-activated lymph node blasts revealed that <10% of the cells were L3T4 + (data not shown) .
Presumably, the biological effects of BSF-1 on T cells are mediated by its binding to specific receptors on the surface of activated T cells analogous to other hormones (35) It is not yet known whether the Th subset(s) that secretes BSF-1 also bears receptors for it, or whether different subsets secrete and bind the ligand or both . In this regard, Mosmann et al . (39) have recently shown the existence of two different types of murine Th clones based on their patterns of lymphokine secretion. Type 1 Th cells produce IL-2, IFN-,y, GM-CSF, and IL-3, whereas Type 2 Th cells produce BSF-1, a mast cell growth factor distinct from IL-3, and a T cell growth factor distinct from IL-2 . The effect of BSF-1 on the proliferation of such clones was not investigated . Nevertheless, the presence of a T cell growth factor activity, different from IL-2 in the SNs of those clones also producing BSF-1 (assayed by proliferation of HT-2 cells), suggests that this T cell growth factor activity might be due to BSF-1 .
Arthur and Mason (42) have also recently reported that inducer/helper T cells in the rat can be separated into two functional subsets based on reactivity with an mAb (MRC OX-22) that recognizes high molecular weight forms of the rat leukocyte-common antigen . One subset (OX-22 +) proliferates well in mixed lymphocyte culture (MLC), responds to Con A, and produces high levels of IL-2 after stimulation; this subset would be expected to play a role in cell-mediated immunity . The other subset (OX-22 -) that proliferates poorly in response to MLC and Con A, produces low levels of IL-2 but provides effective help for B cell responses ; this subset presumably plays an important role in the induction of humoral responses. Based on these data, the rat CD4+, OX-22-subset would be expected to produce (and also respond to) a lymphokine analogous to murine BSF-1 . The effects of BSF-1 on B cell activation and differentiation coupled to its preferential growth-promoting activity on Th cells could provide the means, as suggested by Arthur and Mason (42) , for an independent regulation of cellular and humoral immune responses.
During the past year, the complexity of the biologic activities of BSF-1 has become evident (2-7). Until now, the activity of BSF-1 had been exclusively associated with B cells. This report provides evidence that BSF-I also acts on some T cell subpopulations .
Summary
T cell-derived supernatants (SN) that contain B cell-stimulatory factor 1 (BSF-1) and lack IL-2 promote the growth of the IL-2-dependent T cell line, HT-2, as well as three other clones or lines of T cells that can provide help to B cells. The BSF-I purified from these SNs promotes growth of HT-2 cells -50% as effectively as purified IL-2 . A potential involvement for contaminating IL-2 in the BSF-I preparations was excluded by the demonstration that anti-BSF-I mAbs blocked the BSF-1-induced growth of HT-2 cells ; in contrast, these antibodies did not block the IL-2-induced proliferation of the HT-2 cells. In addition, anti-IL-2 mAbs or anti-IL-2-R antibodies blocked the HT-2 growthpromoting activity of purified IL-2, but not BSF-1 . Finally, BSF-1 promoted only a very modest growth of Con A-induced T cell blasts, and failed to induce significant growth in seven other cytotoxic, alloreactive, and long-term T cell lines. Taken together, these results indicate that in addition to its known effects on resting and LPS-stimulated B cells, BSF-1 can promote growth of certain subsets of activated T cells, in particular, those that provide help to B cells . Note added in proof Lee et al . (43) have recently generated a murine cDNA clone for BSF-1 . Monkey COS cells transfected with this cDNA produce BSF-I . This BSF-1 has la-inducing activity, anti-Ig costimulatory activity, BCDF-y/BCDF-e activity, mast cell stimulatory activity, and HT-2 growth promoting activity. Our results are in agreement with those of Lee et al .
